Profile data is unavailable for this security.
About the company
ProstaLund AB is a Sweden-based company that provides health care products and services. The Company develops and manufactures urological devices and treatments primarily for benign prostatic hyperplasia (BPH). The Company develops CoreTherm, a patented Thermotherapy treatment method for BPH, which takes approximately 6-15 minutes and offers long-term symptom relief. CoreTherm is used in hospitals and clinics in Sweden and worldwide.
- Revenue in SEK (TTM)17.57m
- Net income in SEK-21.64m
- Incorporated2007
- Employees6.00
- LocationProstaLund ABScheelevagen 19LUND 223 63SwedenSWE
- Phone+46 46120908
- Websitehttps://www.prostalund.se/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Level Bio AB (publ) | 24.17m | -10.77m | 19.02m | 11.00 | -- | 3.70 | -- | 0.787 | -0.1688 | -0.1688 | 0.3738 | 0.081 | 1.32 | 5.58 | 5.13 | 1,858,971.00 | -58.81 | -6.39 | -100.69 | -10.51 | -3.92 | -- | -44.55 | -4.09 | 0.8205 | -145.54 | 0.00 | -- | -23.10 | 7.83 | -326.08 | -- | -4.64 | -- |
| Perpetua Medical AB (publ) | 6.32m | -8.48m | 19.90m | 0.00 | -- | 1.93 | -- | 3.15 | -3.06 | -3.06 | 1.91 | 2.28 | 0.4074 | 16.13 | 6.19 | -- | -54.70 | -83.52 | -74.20 | -102.19 | -65.03 | -70.52 | -134.27 | -250.30 | 6.39 | -- | 0.00 | -- | -1.76 | 57.20 | 4.63 | -- | 8.89 | -- |
| Codelab Capital AS | -98.35bn | -98.35bn | 20.17m | 29.00 | -- | 0.1298 | -- | -- | -- | -- | -- | 0.4624 | -- | -- | -- | -- | -- | -6.63 | -- | -7.43 | -- | 83.80 | -- | -39.82 | -- | -- | 0.00 | -- | -69.66 | -3.83 | 119.43 | -- | -12.19 | -- |
| Miris Holding AB (publ) | 17.32m | -9.41m | 20.46m | 10.00 | -- | 4.99 | -- | 1.18 | -0.2092 | -0.2092 | 0.3641 | 0.0271 | 0.824 | 0.1117 | 7.25 | 1,732,100.00 | -44.74 | -59.61 | -95.35 | -111.08 | 97.83 | 86.68 | -54.30 | -103.61 | 0.7091 | -8.08 | 0.0903 | -- | -17.19 | 2.53 | -20.86 | -- | -- | -- |
| Chordate Medical Holding AB (publ) | 1.12m | -27.82m | 23.72m | 3.00 | -- | 1.14 | -- | 21.12 | -41.97 | -41.97 | 1.67 | 21.16 | 0.0363 | -0.746 | 3.53 | 374,390.00 | -90.02 | -91.98 | -110.15 | -122.85 | 219.20 | 209.52 | -2,477.25 | -3,295.75 | 2.34 | -- | 0.00 | -- | 799.63 | 0.6511 | -4.45 | -- | -- | -- |
| Bio Vitos Pharma AB | 1.11m | -14.84m | 26.40m | 1.00 | -- | 0.7407 | -- | 23.81 | -1.50 | -1.50 | 0.0597 | 0.9046 | 0.0457 | 0.092 | 3.02 | 1,108,910.00 | -61.08 | -31.11 | -62.90 | -32.92 | 90.59 | -- | -1,338.03 | -1,026.76 | 5.84 | -- | 0.00 | -- | 126.97 | -- | 13.64 | -- | -- | -- |
| Inhalation Sciences Sweden AB | 15.48m | -3.93m | 26.92m | 8.00 | -- | 2.40 | -- | 1.74 | -0.2796 | -0.2796 | 1.09 | 0.7409 | 0.8096 | 0.6328 | 4.37 | 1,935,000.00 | -20.53 | -27.93 | -29.23 | -43.82 | 86.29 | 71.13 | -25.36 | -48.02 | 2.81 | -6.49 | 0.0639 | -- | 43.55 | 26.33 | 60.87 | -- | -- | -- |
| ProstaLund AB | 17.57m | -21.64m | 32.97m | 6.00 | -- | 0.4738 | -- | 1.88 | -0.2752 | -0.2752 | 0.2226 | 0.5656 | 0.2627 | 0.3308 | 12.78 | -- | -32.35 | -29.14 | -39.54 | -35.01 | 72.73 | 75.26 | -123.16 | -68.94 | 0.7618 | -155.80 | 0.1065 | -- | 27.54 | 10.36 | -53.27 | -- | 20.35 | -- |
| BBS-Bioactive Bone Substitutes Oyj | 0.00 | -41.23m | 34.05m | -- | -- | 0.6459 | -- | -- | -0.2069 | -0.2069 | 0.00 | 0.1765 | 0.00 | -- | -- | -- | -35.38 | -25.12 | -45.41 | -28.54 | -- | -- | -- | -- | -- | -27.51 | 0.5953 | -- | -- | -- | -12.64 | -- | -- | -- |
| Scandinavian ChemoTech AB | 5.03m | -15.70m | 39.26m | 5.00 | -- | 4.71 | -- | 7.80 | -0.8655 | -0.8655 | 0.2647 | 0.384 | 0.3162 | 0.5947 | 1.37 | 838,666.70 | -98.64 | -87.29 | -98.64 | -118.55 | 29.67 | 252.05 | -311.96 | -2,122.77 | -- | -22.93 | 0.00 | -- | 496.62 | 19.13 | 7.28 | -- | -- | -- |
| Scandinavian Real Heart AB | 0.00 | -75.02m | 39.40m | 12.00 | -- | 0.4305 | -- | -- | -0.5182 | -0.5182 | 0.00 | 0.4425 | 0.00 | -- | -- | 0.00 | -73.46 | -24.27 | -87.03 | -26.81 | -- | 832.41 | -- | -6,070.11 | -- | -700.38 | 0.1023 | -- | -100.00 | -- | -385.97 | -- | -25.76 | -- |
Data as of Nov 11 2024. Currency figures normalised to ProstaLund AB's reporting currency: Swedish Krona SEK
0.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| FCG Fonder ABas of 30 Sep 2024 | 15.11k | 0.01% |
Data from 31 Oct 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
